Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Dr Reddy’s Laboratories launches Redyx (remdesivir) in India
It is available in the strength of 100 mg vial
TN’s industrial policy shall offer specific higher incentives for sunrise sectors
Dr Neeraj Mittal, MD & CEO, Guidance, Industries Department, Government of Tamil Nadu showcases how the State is an ideal…
Neovascularization inhibitor sales will near $7 bn in diabetic retinopathy market in 2029:…
This increase is expected to be driven by the demonstrable efficacy of these products in reducing the rate of angiogenesis and…
Cadila Pharma launches Obetocad, generic obeticholic acid for liver therapy
Obetocad can be used as a monotherapy or along with UDCA for treatment of patients with primary biliary cholangitis who are…
SIRO and AZIDUS enter into an alliance
The partnership will help expand services and market share for both the CROs
AstraZeneca stops COVID-19 vaccine trial due to unexplained illness in participant
A participant was found to have transverse myelitis, an inflammatory syndrome that affects the spinal cord and is often sparked by…
NPPA is readying mechanism to ease COVID-19 vaccine supply, prevent unethical practices
The government is in talks with experts and stakeholders to increase access to COVID-19 vaccines, bring down their costs and…
Nine COVID-19 vaccine makers sign safety pledge
The companies said in a statement they would uphold the integrity of the scientific process as they work towards potential global…
E-pharma set to revolutionise drug market access in India: GlobalData
E-pharma companies will offer competitive pricing and access to quality medicines even in remote places along with the ease of…
Takeda sells select non-core assets in Europe to Cheplapharm for about $562 mn
Portfolio includes prescription products in Takeda’s cardiovascular/metabolic and anti-inflammatory therapeutic areas along with…